• Explore /
  • Poster
  • / Intracranial efficacy of sotorasib versus docetaxel in pretreated<em> KRAS</em> G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT).

Intracranial efficacy of sotorasib versus docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT).

Abstract Poster

Authors

Anne-Marie Dingemans

Anne-Marie C. Dingemans

Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands

Anne-Marie C. Dingemans , Konstantinos Syrigos , Lorenzo Livi , Astrid Paulus , Sang-We Kim , Yuanbin Chen , Enriqueta Felip , Frank Griesinger , Kadoaki Ohashi , Gerard Zalcman , Brett Gordon Maxwell Hughes , Jens Benn Sorensen , Normand Blais , Carlos G. M. Ferreira , Colin R Lindsay , Rafal Dziadziuszko , Patrick J. Ward , Cynthia Chinedu Obiozor , Yang Wang , Solange Peters

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT04303780

Citation

J Clin Oncol 41, 2023 (suppl 17; abstr LBA9016)

DOI

10.1200/JCO.2023.41.17_suppl.LBA9016

Abstract #

LBA9016

Poster Bd #

4

Abstract Disclosures

Similar Posters

First Author: David S. Hong

First Author: Federico Cappuzzo

First Author: Sukhmani Kaur Padda

First Author: Joshua E. Reuss